White Paper – The Business Case for a Circular MedTech Sector

In Insights

15 April, 2021

This whitepaper demonstrates that the efforts of private companies towards circularity can in fact lead to a more sustainable medtech sector. Sustainable solutions in the field have the potential to not only reduce greenhouse gas emissions, but importantly also address a range of issues related to pollution and waste.

The effects should benefit natural environments and human health alike, and bring the industry in line with the scope of international agreements on sustainability such as the Paris Agreement of 2015. The move towards circularity constitutes a solid business case for competitive medtech companies.

This whitepaper is a result of a joint effort between AWA, Green Innovation Group and Matter.

[download_after_email id=”4513″]

You may also be interested in:

EPO launches new PPH agreements with New Zealand and Bahrain

The PPH network continues to expand, and we at AWA remain one step ahead by closely monitoring the new

Read more...

Increasing Burden of Proof for Trademark Applicants in China

Based on the recent official notices issued by the CNIPA (China National Intellectual Property Administration) about non-use cancellation cases,

Read more...

Companies with IP generate at least 23.8% more revenue according to latest EU report

The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses

Read more...

Mobile Sliding Menu